HKU Scholars Hub: Search

Search

Results 1-25 of 91 (Search time: 0.039 seconds).

previous
1
2
3
4
next

	Title	Author(s)	Issue Date	Views
	Characterizing immune-mediated adverse events with durvalumab in patients with unresectable stage III NSCLC: A post-hoc analysis of the PACIFIC trial Journal:Lung Cancer	Naidoo, Jarushka Vansteenkiste, Johan F.Faivre-Finn, Corinne Özgüroğlu, Mustafa Murakami, Shuji Hui, Rina Quantin, Xavier Broadhurst, Helen Newton, Michael Thiyagarajah, Piruntha Antonia, Scott J.	2022
	Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer Journal:Journal of Clinical Oncology	Spigel, David R.Faivre-Finn, Corinne Gray, Jhanelle E.Vicente, David Planchard, David Paz-Ares, Luis Vansteenkiste, Johan F.Garassino, Marina C.Hui, Rina Quantin, Xavier Rimner, Andreas Wu, Yi Long Özgüroǧlu, Mustafa Lee, Ki H.Kato, Terufumi De Wit, Maike Kurata, Takayasu Reck, Martin Cho, Byoung C.Senan, Suresh Naidoo, Jarushka Mann, Helen Newton, Michael Thiyagarajah, Piruntha Antonia, Scott J.	2022
	Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial Journal:ESMO Open	Senan, S.Özgüroğlu, M.Daniel, D.Villegas, A.Vicente, D.Murakami, S.Hui, R.Faivre-Finn, C.Paz-Ares, L.Wu, Y. L.Mann, H.Dennis, P. A.Antonia, S. J.	2022
	Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies Journal:Journal for ImmunoTherapy of Cancer	Schöffski, Patrick Tan, Daniel S.W.Martín, Miguel Ochoa-De-Olza, Mariá Sarantopoulos, John Carvajal, Richard D.Kyi, Chrisann Esaki, Taito Prawira, Amy Akerley, Wallace De Braud, Filippo Hui, Rina Zhang, Tian Soo, Ross A.Maur, Michela Weickhardt, Andrew Krauss, Jürgen Deschler-Baier, Barbara Lau, Allen Samant, Tanay S.Longmire, Tyler Chowdhury, Niladri Roy Sabatos-Peyton, Catherine A.Patel, Nidhi Ramesh, Radha Hu, Tiancen Carion, Ana Gusenleitner, Daniel Yerramilli-Rao, Padmaja Askoxylakis, Vasileios Kwak, Eunice L.Hong, David S.	2022
	Five-year survival and clinical correlates among patients with advanced non-small cell lung cancer, melanoma and renal cell carcinoma treated with immune check-point inhibitors in Australian tertiary oncology centres Journal:Cancer Medicine	Brown, Lauren J.da Silva, Ines Pires Moujaber, Tania Gao, Bo Hui, Rina Gurney, Howard Carlino, Matteo Nagrial, Adnan	2022
	Cyclin-dependent kinases as downstream targets of oestrogen action: Potential prognostic indicators and therapeutic targets Journal:Endocrine-Related Cancer	Sutherland, R. L.Prall, O. W.J.Alle, K. M.Wilcken, N. R.C.Hui, R.Ball, J. R.Sarcevic, B.Henshall, S. M.Musgrove, E. A.Watts, C. K.W.	1997
	Cyclin D1 Overexpression Induces Progestin Resistance in T-47D Breast Cancer Cells Despite p27<sup>Kip1</sup> Association with Cyclin E-Cdk2 Journal:Journal of Biological Chemistry	Musgrove, Elizabeth A.Hunter, Lisa Jane K.Lee, Christine S.L.Swarbrick, Alexander Hui, Rina Sutherland, Robert L.	2001
	Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells Journal:Cancer Research	Hui, Rina Finney, Georgina L.Carroll, Jason S.Lee, Christine S.L.Musgrove, Elizabeth A.Sutherland, Robert L.	2002
	Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells Proceeding/Conference:Endocrine-Related Cancer	Doisneau-Sixou, S. F.Sergio, C. M.Carroll, J. S.Hui, R.Musgrove, E. A.Sutherland, R. L.	2003
	Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer Journal:Clinical Cancer Research	Hui, Rina Cornish, Ann L.McClelland, Richard A.Robertson, John F.R.Blamey, Roger W.Musgrove, Elizabeth A.Nicholson, Robert I.Sutherland, Robert L.	1996
	Cyclins and breast cancer. Journal:Journal of mammary gland biology and neoplasia	Musgrove, E. A.Hui, R.Sweeney, K. J.Watts, C. K.Sutherland, R. L.	1996
	EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer Journal:Oncogene	Hui, Rina Campbell, Douglas H.Lee, Christine S.L.McCaul, Kieran Horsfall, David J.Musgrove, Elizabeth A.Daly, Roger J.Seshadri, Ram Sutherland, Robert L.	1997
	Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer Journal:Clinical Cancer Research	Kenny, Frances S.Hui, Rina Musgrove, Elizabeth A.Gee, Julia M.W.Blamey, Roger W.Nicholson, Robert I.Sutherland, Robert L.Robertson, John F.R.	1999
	Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression Journal:International Journal of Cancer	Yip, Sonia S.Crew, A. Jayne Gee, Julia M.W.Hui, Rina Blamey, Roger W.Robertson, John F.R.Nicholson, Robert I.Sutherland, Robert L.Daly, Roger J.	2000
	INK4a gene expression and methylation in primary breast cancer: Overexpression of p16(INK4a) messenger RNA is a marker of poor prognosis Journal:Clinical Cancer Research	Hui, Rina Macmillan, R. Douglas Kenny, Frances S.Musgrove, Elizabeth A.Blamey, Roger W.Nicholson, Robert I.Robertson, John F.R.Sutherland, Robert L.	2000
	Radiotherapy and concurrent chemotherapy for oesophageal carcinoma Journal:Australasian Radiology	HUI, RINA BULL, COLIN A.GEBSKI, VAL O'ROURKE, IAN	1994
	Cyclin D1 amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis Journal:Clinical Cancer Research	Seshadri, Ram Lee, Christine S.L.Hui, Rina McCaul, Kieran Horsfall, David J.Sutherland, Robert L.	1996
	Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC) Journal:Clinical Lung Cancer	Socinski, Mark A.Özgüroğlu, Mustafa Villegas, Augusto Daniel, Davey Vicente, David Murakami, Shuji Hui, Rina Gray, Jhanelle E.Park, Keunchil Vincent, Mark Mann, Helen Newton, Michael Dennis, Phillip A.Antonia, Scott J.	2021
	Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042 Proceeding/Conference:JTO Clinical and Research Reports	Mansfield, Aaron S.Herbst, Roy S.de Castro, Gilberto Hui, Rina Peled, Nir Kim, Dong Wan Novello, Silvia Satouchi, Miyako Wu, Yi Long Garon, Edward B.Reck, Martin Robinson, Andrew G.Samkari, Ayman Piperdi, Bilal Ebiana, Victoria Lin, Jianxin Mok, Tony S.K.	2021
	Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing Journal:Breast Cancer Research and Treatment	Dinh, Phuong Graham, J. Dinny Elder, Elisabeth N.Kabir, Masrura Doan, Tram B.French, James Meybodi, Farid Hui, Rina Wilcken, Nicholas R.Harnett, Paul R.Hsu, Jeremy Stuart, Kirsty E.Wang, Tim Ahern, Verity Brennan, Meagan Fox, Stephen B.Dear, Rachel F.Lim, Elgene White, Michelle Mann, G. Bruce Pathmanathan, Nirmala	2022
	Occult metastatic thyroid cancer diagnosed during breast cancer axillary sentinel node biopsy Journal:Endocrinology, Diabetes and Metabolism Case Reports	Herle, Pratima Boyages, Steven Hui, Rina Nahar, Najmun Ngui, Nicholas K.	2020
	Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial Journal:Clinical Breast Cancer	Chan, Arlene Moy, Beverly Mansi, Janine Ejlertsen, Bent Holmes, Frankie Ann Chia, Stephen Iwata, Hiroji Gnant, Michael Loibl, Sibylle Barrios, Carlos H.Somali, Isil Smichkoska, Snezhana Martinez, Noelia Alonso, Mirta Garcia Link, John S.Mayer, Ingrid A.Cold, Søren Murillo, Serafin Morales Senecal, Francis Inoue, Kenichi Ruiz-Borrego, Manuel Hui, Rina Denduluri, Neelima Patt, Debra Rugo, Hope S.Johnston, Stephen R.D.Bryce, Richard Zhang, Bo Xu, Feng Wong, Alvin Martin, Miguel	2021
	Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC) Journal:Lung Cancer	Faivre-Finn, Corinne Spigel, David R.Senan, Suresh Langer, Corey Perez, Bradford A.Özgüroğlu, Mustafa Daniel, Davey Villegas, Augusto Vicente, David Hui, Rina Murakami, Shuji Paz-Ares, Luis Broadhurst, Helen Wadsworth, Catherine Dennis, Phillip A.Antonia, Scott J.	2021
	Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial Journal:Annals of Oncology	Paz-Ares, L.Spira, A.Raben, D.Planchard, D.Cho, B. C.Özgüroğlu, M.Daniel, D.Villegas, A.Vicente, D.Hui, R.Murakami, S.Spigel, D.Senan, S.Langer, C. J.Perez, B. A.Boothman, A. M.Broadhurst, H.Wadsworth, C.Dennis, P. A.Antonia, S. J.Faivre-Finn, C.	2020
	Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer Journal:Asia-Pacific Journal of Clinical Oncology	de Boer, Richard Hui, Rina Lim, Elgene Yeo, Belinda Zdenkowski, Nicholas	2020